Wright Medical Group, Inc. Announces Agreement with FDA Office of Device Evaluation to File PMA Amendment for Augment® ...

Wright Medical Group, Inc. today announced it has reached an agreement with the Office of Device Evaluation of the U.S. Food and Drug Administration under which ODE will accept a further amendment to the Pre-Market Approval application for Augment® Bone Graft in lieu of proceeding with the Dispute Resolution Panel that was scheduled for the week of May 19, 2014.



from Google News, Yahoo! News, Wikinews, NY Times National News by search term http://ift.tt/1lPFrTh

via IFTTT